Sintx Technologies (SINT) Expected to Post Earnings on Tuesday

Sintx Technologies (NASDAQ:SINT) will likely be issuing its Q2 2026 results before the market opens on Tuesday, August 11th. Analysts expect Sintx Technologies to post earnings of ($0.69) per share and revenue of $0.46 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Tuesday, August 11, 2026 at 4:30 PM ET.

Sintx Technologies (NASDAQ:SINT) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04). The business had revenue of $0.38 million for the quarter, compared to the consensus estimate of $0.30 million. Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%. On average, analysts expect Sintx Technologies to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Sintx Technologies Trading Down 5.0%

Shares of SINT traded down $0.09 during trading hours on Tuesday, reaching $1.68. 12,880 shares of the company traded hands, compared to its average volume of 40,076. The stock’s fifty day moving average price is $1.89 and its 200 day moving average price is $2.46. The firm has a market cap of $7.26 million, a price-to-earnings ratio of -0.33 and a beta of 0.62. Sintx Technologies has a 12-month low of $1.40 and a 12-month high of $6.78.

Analyst Ratings Changes

SINT has been the topic of a number of research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. Ascendiant Capital Markets dropped their price objective on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. Maxim Group reiterated a “buy” rating and issued a $6.00 target price on shares of Sintx Technologies in a report on Thursday, June 4th. Finally, HC Wainwright reissued a “buy” rating and set a $10.00 price target on shares of Sintx Technologies in a research report on Wednesday, May 20th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $9.33.

Hedge Funds Weigh In On Sintx Technologies

A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC increased its position in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,624 shares of the company’s stock after acquiring an additional 9,265 shares during the quarter. Geode Capital Management LLC owned about 0.72% of Sintx Technologies worth $103,000 as of its most recent SEC filing. Institutional investors own 18.38% of the company’s stock.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.